AUS
NZ
UK
CA
USA
IND
Healt
Telix Faces Regulatory Setback as FDA Requests More Data on Brain Cancer Imaging Agent
April 28, 2025 11:54 AM AEST| By Team Kalkine MediaHighlights,Telix,faces regulatory setback on brain cancer imaging agent,FDA requests more clinical evidence for approval,Company plans swift resubmission after addressing feedback,Shares of Telix Pharmaceuticals (ASX:TLX) fell nearly 6% on Monday aft...
SomnoMed Limited (ASX:SOM): A Comprehensive Look at Recent Performance
April 26, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,SomnoMed shares have seen a notable decline in recent weeks.,Despite recent challenges, the company has exhibited strong year-over-year growth.,The company's price-to-sales ratio reflects cautious investor sentiment.,SomnoMed Limited, lis...
Determining the Intrinsic Value of Alcidion Group Limited (ASX:ALC)
April 25, 2025 10:32 PM AEST| By Team Kalkine MediaHighlights:,Alcidion Group's share price closely reflects its estimated equity valuation derived from discounted cash flow modelling,The company maintains a debt-free structure with projected profitability supported by a strong cash position,Price-to...
Micro-X Insider Stock Buyers Recover Some Losses This Week
April 25, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,Micro-X insiders hold a significant stake in the company, with a substantial portion of shares owned by those directly involved.,A noteworthy acquisition by Chairman Patrick O'Brien highlights confidence in the company's future.,Insider t...
Recce Pharmaceuticals Prepares for Pivotal Trials with A$15.8 Million Funding Injection
April 24, 2025 07:00 PM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals secures A$15.8 million for pivotal Phase 3 trials.,Key focus on diabetic foot infections and skin infections across Asia-Pacific and Australia.,US clinical plans advance with FDA submission in view for late 2025.,Recc...
ResMed’s (ASX:RMD) Robust Growth Driven by Demand for Sleep Apnoea Solutions
April 24, 2025 06:44 PM AEST| By Team Kalkine MediaHighlights,ResMed delivers strong double-digit EPS growth.,Robust demand for sleep apnoea devices drives revenue.,New home-based diagnostic test expands patient access.,ResMed (ASX:RMD), a global leader in digital health and sleep technology, has rep...
ASX Healthcare Focus: Exploring Cochlear Ltd (ASX:COH) Amid Sector Trends
April 24, 2025 06:26 PM AEST| By Team Kalkine MediaHighlights:,Cochlear Ltd has recorded a share price decline since the beginning of the year,The company manufactures hearing implants and operates in over fifty countries,Broader ASX healthcare sector has seen muted returns over the past several year...
ResMed (ASX:RMD) Reports Strong FY25 Q3 Performance Driving Share Price Surge
April 24, 2025 06:17 PM AEST| By Team Kalkine MediaHighlights:,ResMed’s revenue increased driven by performance across all major markets and product segments,Net profit recorded double-digit growth supported by expanded gross margins,Gross profit margin improved due to product mix and operational eff...
Telix Pharmaceuticals: A Rapidly Growing Force in Cancer Treatment
April 24, 2025 06:12 PM AEST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals has experienced rapid revenue growth, reaching over one billion dollars in sales.,The company specializes in radiotherapy treatments for cancer, primarily marketed in the U.S.,Despite a notable rise in share value, e...
Botanix's SODFRA Sales Surge in Q1, Boosting Confidence in Expansion Strategy
April 24, 2025 06:12 PM AEST| By Team Kalkine MediaHighlights,Q1 revenue from SODFRA doubles between Feb and Mar,$40M raised via institutional placement,Expansion plans supported by strong cash reserves,Botanix Pharmaceuticals (ASX:BOT) has reported a strong commercial debut for its newly launched de...
ResMed Navigates International Trade Policy with Tariff Exemption
April 24, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,ResMed (ASX:RMD) secured a tariff exemption from the U.S. for products shipped from Australia and Singapore.,The exemption is tied to the Nairobi Protocol, which supports trade in products aiding individuals with disabilities.,Broader unc...
ResMed Soars on Robust Q3 Performance, Driven by Strong Product Demand and Margin Growth
April 24, 2025 11:39 AM AEST| By Team Kalkine MediaHighlights,ResMed reports 21% surge in quarterly earnings,Revenue hits US$1.29 billion on rising demand for sleep health devices,Gross margin expands to 59.3% on product mix and operational efficiency,ResMed (ASX:RMD) shares climbed over 8% to $35.99...
ResMed Secures Tariff Exemption, Boosts US Presence Amid Trade Tensions
April 24, 2025 10:53 AM AEST| By Team Kalkine MediaHighlights,ResMed receives exemption from US trade tariffs,Expands US manufacturing to manage policy uncertainty,Q3 revenue grows 8% to $US1.3 billion,Global sleep technology company ResMed (ASX:RMD) has announced that its products manufactured in Au...
Telix Pharmaceuticals Drives Growth Surge Among ASX Healthcare Stocks
April 23, 2025 04:55 PM AEST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals has expanded its revenues significantly within a few years, marking a sharp rise in commercial success.,The company has progressed from regulatory approvals to successful diagnostic and therapeutic product rollouts.,...
Cochlear Limited (ASX:COH) Navigates Market Pressures with Long-Term Resilience
April 23, 2025 04:33 PM AEST| By Team Kalkine MediaHighlights,Cochlear shares have declined in the recent quarter but maintain notable growth over an extended period,Shareholder return outpaces stock price gains due to consistent dividend contributions,Company records multiple senior-level stock acqu...
NeuroScientific Biopharmaceuticals (ASX:NSB) Shares Advance as Market Reassesses Valuation
April 23, 2025 04:32 PM AEST| By Team Kalkine MediaHighlights,NeuroScientific Biopharmaceuticals Limited stock price rose significantly over the past month,Company’s valuation remains below broader market averages based on earnings multiples,Earnings have improved recently, though longer-term trends...
We Are Monitoring Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Rate
April 23, 2025 04:32 PM AEST| By Team Kalkine MediaHighlights,Paradigm Biopharmaceuticals reported a significant year-on-year reduction in cash usage,Cash reserves remain above spending levels, offering a manageable funding horizon,Future capital requirements could lead to shareholder dilution if equ...
If you had invested in Ansell (ASX:ANN) a year ago, you would have achieved a 13% gain.
April 23, 2025 04:30 PM AEST| By Team Kalkine MediaHighlights,Ansell shares declined in the recent quarter but recorded year-on-year gains.,Revenue growth surpassed earnings performance over the last twelve months.,Total shareholder return outpaced share price movement due to dividend contributions.,...
FDA Clearance Drives Orthocell (ASX:OCC) Momentum Among ASX Healthcare Stocks
April 23, 2025 04:04 PM AEST| By Team Kalkine MediaHighlights:,Orthocell announces distributor agreements across key US regions for its flagship medical product,FDA clearance enables immediate commercial rollout in the US healthcare market,Remplir collagen wrap to be promoted by regional specialists...
Lumos Diagnostics (ASX:LDX) Expands Medicare Coverage for FebriDx Test in the US
April 23, 2025 02:10 PM AEST| By Team Kalkine MediaHighlights,Medicare expansion boosts diagnostic reach,FebriDx now covered by 55% of US Medicare,Lumos eyes full national adoption,Lumos Diagnostics (ASX:LDX) has achieved a major milestone in its US commercialization efforts, securing additional Medi...
Advertise your brand on Kalkine Media